Compare RLX Technology Inc (RLX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
RLX Technology Inc vs Tenet Healthcare Corporation — how do they compare? RLX Technology Inc trades at $1.77 (market cap $2.19B), while Tenet Healthcare Corporation trades at $269.36 (market cap $20.86B). The key difference: Tenet Healthcare Corporation is far larger — about 9.5× RLX Technology Inc's market cap, and RLX Technology Inc pays a 5.59% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| RLX | THC | |
|---|---|---|
Market Cap | $2.19B | $20.86B |
Sector | Technology | Health |
52-Week High | $2.69 | $280.77 |
52-Week Low | $1.76 | $161.37 |
Enterprise Value | $919.18M | $31.94B |
Dividend Yield | 5.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RLX trades at $1.79, down 0.56% on the day, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue growth of 14.8% year-over-year, driven by international expansion, though it missed EPS estimates for the third consecutive quarter. Profitability remains solid with a net income margin of 21.87% and a P/E ratio of 16.1, indicating reasonable valuation.
The outlook is mixed; international growth offers opportunity, but consistent earnings misses and a sole 'Hold' analyst rating suggest caution. Key risks include execution in new markets and regulatory scrutiny. The stock lacks bullish momentum but holds fundamental strength if expansion delivers.
Tenet Healthcare (THC) trades at $259.06, down 2.26% today, with a bearish technical signal but strong fundamentals. The stock exhibits robust profitability with an 82.83% gross margin and 53.31% ROE, supported by three consecutive quarterly EPS beats. Recent news includes a $2.0 billion senior notes offering for refinancing and participation in the Wells Fargo Healthcare Conference.
Outlook remains positive given analyst consensus of 81.25% buy ratings and a $281.44 price target, implying 8.6% upside. Risks include debt refinancing execution and healthcare regulatory pressures, but earnings momentum and valuation multiples below industry averages present a compelling opportunity for value investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
